Additionally, studies have shown that sphingosine 1-phosphate can protect the kidney with AKI by activating sphingosine 1-phosphate receptors [35], and the magnitude of this protective effect was reduced when the sphingosine 1-phosphate levels in the CDDP group were decreased. This evidence concerns the gene S1PR1 and acute kidney injury.